1. A multicenter, randomized, dose-finding study of mechanochemical ablation using ClariVein and liquid polidocanol for great saphenous vein incompetence
- Author
-
I. Nagtzaam, Y.L. Lam, C.H.A. Wittens, A. A. E. A. De Smet, Fred H. M. Nieman, J.A. Lawson, Anco C. Vahl, Michiel A. Schreve, T. Alozai, Dermatology, MUMC+: MA AIOS Dermatologie (6), MUMC+: MA Dermatologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Dermatologie, and MUMC+: MA AIOS Dermatologie (9)
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Polidocanol ,THERMAL ABLATION ,CHRONIC VENOUS DISORDERS ,CLINICAL-TRIAL ,Dose finding ,INSUFFICIENCY ,Endovenous ablation ,Occlusion ,Varicose veins ,medicine ,Humans ,VARICOSE-VEINS ,Saphenous Vein ,Single-Blind Method ,FOAM SCLEROTHERAPY ,ENDOVENOUS LASER-ABLATION ,RADIOFREQUENCY ABLATION ,Vein ,Mechanochemical ablation ,business.industry ,STATEMENT ,Endovascular Procedures ,Great saphenous vein ,ClariVein ,Ablation ,Surgery ,REVISION ,Treatment Outcome ,medicine.anatomical_structure ,Venous Insufficiency ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
BACKGROUND: The purpose of the present study was to identify the ideal polidocanol (POL) concentration for mechanochemical ablation (MOCA) of the great saphenous vein (GSV) using the ClariVein system (Merit Medical, South Jordan, Utah).METHODS: We performed a multicenter, randomized, controlled, single-blind trial with a follow-up period of 6 months. Patients with symptomatic primary truncal GSV incompetence were randomized to MOCA + 2% POL liquid (2% group) or MOCA + 3% POL liquid (3% group). The primary outcome was technical success (TS), defined as an open part of the treated vein segment of ≤10 cm in length. The secondary outcomes were alternative TS, defined as ≥85% occlusion of the treated vein segment, postoperative pain, venous clinical severity scores, Aberdeen varicose vein questionnaire scores, and short-form 36-item health survey questionnaire scores, and complications.RESULTS: From 2012 to 2018, 364 patients (375 limbs) were included, of which, 189 limbs were randomly allocated to the 2% group and 186 to the 3% group. The TS rate at 6 months was 69.8% in the 2% group vs 78.0% in the 3% group (P = .027). A higher overall TS rate was seen in GSVs of ≤5.9 mm compared with GSVs >5.9 mm (84.3% vs 59.5%, respectively; P < .001). The alternative TS rate at 6 months was 61.4% in the 2% group and 67.7% in the 3% group (P = .028). The venous clinical severity scores, Aberdeen varicose vein questionnaire scores, and most short-form 36-item health survey questionnaire domains had improved in both groups (P < .002). Postprocedural pain was low. Two pulmonary embolisms and two deep vein thromboses were seen. Superficial venous thrombosis had occurred more often in the 3% group (18 vs 8 in the 2% group; P = .033).CONCLUSIONS: The results from the present study showed a higher success rate for MOCA with 3% POL liquid than for MOCA with 2% POL liquid at 6 months of follow-up. However, the difference in quality of life was not significant. Long-term follow-up studies are required to investigate whether these results will be sustained in the future.
- Published
- 2022